Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL7326509

CC(CC(=O)O)N1CC(=O)N(C(C)C)c2ccc(CCCCOc3cccnc3N)cc2C1=O.O=C(O)C(F)(F)F

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 7/20 0.37
ITGA2B P08514 7/20 0.37
RXRA P19793 3/20 0.36
ITGA2 P17301 1/20 0.31
TAAR1 Q96RJ0 1/20 0.30
TBXA2R P21731 1/20 0.30
PTGER4 P35408 1/20 0.30
PTGFR P43088 1/20 0.30
PTGER3 P43115 1/20 0.30
PTGER2 P43116 1/20 0.30
PTGIR P43119 1/20 0.30
PTGDR Q13258 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL7322226 0.92 ITGB3 (0.46) ITGB3ITGA2BRXRAITGA2TAAR1
Trifluoroacetic Acid SCHEMBL7319152 0.92 MEN1 (0.37) ITGB3ITGA2BRXRA
SCHEMBL7326515 0.91 RXRA (0.32) ITGB3ITGA2BRXRA
Trifluoroacetic Acid SCHEMBL7327342 0.90 ITGB3 (0.37) ITGB3ITGA2BRXRAITGA2TAAR1
Trifluoroacetic Acid SCHEMBL9009478 0.89 PTGDR2 (0.36) ITGB3ITGA2B
SCHEMBL7319156 0.86 MEN1 (0.33) RXRA
SCHEMBL7331254 0.84 PTGDR2 (0.39) ITGB3ITGA2B
Trifluoroacetic Acid SCHEMBL7326440 0.84 ITGB3 (0.42) ITGB3ITGA2BRXRAITGA2
Trifluoroacetic Acid SCHEMBL7321436 0.83 MDM2 (0.32) RXRATAAR1
Trifluoroacetic Acid SCHEMBL7332678 0.83 MEN1 (0.38) ITGB3ITGA2BRXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5663166-A ANTICOAGULANTS OF 1,4-BENZODIAZEPINE-2,5-DIONE AND 2-BENZOAZEPINE-1,4-DIONE DERIVATIVES; PREVENTS FIBRINOGEN BINDING NECESSARY FOR PLATELET AGGREGATION; SIDE EFFECT REDUCTION, E.G. EXCESSIVE BLEEDING GENENTECH, INC. (US) 1997-09-02 US disclosed
US-5565449-A PLATELET AGGREGATION INHIBITORS GENENTECH, INC. (US) 1996-10-15 US disclosed
EP-0610334-B1 NONPEPTIDYL INTEGRIN INHIBITORS HAVING SPECIFICITY FOR THE GPII B III A RECEPTOR GENENTECH INC (US) 1996-01-24 EP disclosed
US-5403836-A Anticoagulants GENENTECH, INC. (US) 1995-04-04 US disclosed
US-5250679-A Nonpeptidyl platelet aggregation inhibitors having specificity for the GPIIb III.sub. receptor GENENTECH, INC. (US) 1993-10-05 US disclosed
WO-1993008174-A1 NONPEPTIDYL INTEGRIN INHIBITORS HAVING SPECIFICITY FOR THE GPIIbIIIa RECEPTOR GENENTECH, INC. (US) 1993-04-29 WO disclosed